Related Experiment Video
Updated: Jul 8, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
Pathogenic TDP-43 accelerates the generation of toxic exon1 HTT in Huntington's disease knock-in mice
Dazhang Bai1,2, Fuyu Deng1,3, Qingqing Jia1
1State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Key Laboratory of non-human Primate Research, Guangdong-Hongkong-Macau Institute of CNS Regeneration, Jinan University, Guangzhou, Guangdong, China.
Insights
Cytoplasmic TDP-43 accumulation in Huntington's disease (HD) models exacerbates motor deficits. This mislocalized TDP-43 binds Htt pre-mRNA, promoting toxic protein production and contributing to HD pathogenesis.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Huntington's disease (HD) results from CAG repeat expansion in the HTT gene, leading to toxic huntingtin protein fragments.
- TDP-43 is typically nuclear but mislocalizes to the cytoplasm in pathological conditions.
Purpose of the Study:
- To investigate the role of cytoplasmic TDP-43 in Huntington's disease pathogenesis using HD knock-in mouse models.
- To determine if TDP-43 mislocalization contributes to disease progression and aberrant protein generation.
Main Methods:
- Utilized HD knock-in mice expressing a cytoplasmic TDP-43 variant lacking a nuclear localization signal.
- Analyzed TDP-43 localization and its impact on motor and gait behavior in mouse models.
- Investigated TDP-43 binding to Htt pre-mRNA and its effect on exon1 Htt generation.
Main Results:
- Increased cytoplasmic TDP-43 was observed in the brains of HD mice.
- Cytoplasmic TDP-43 mislocalization correlated with worsened motor and gait behavior.
- Cytoplasmic TDP-43 binds to Htt pre-mRNA intron1, promoting the ribosomal transport and aberrant generation of exon1 Htt.
Conclusions:
- Cytoplasmic TDP-43 is a key contributor to Huntington's disease pathogenesis.
- TDP-43's aberrant transport of Htt pre-mRNA to ribosomes generates toxic protein products, driving disease progression.
Abstract:
Huntington's disease (HD) is caused by a CAG repeat expansion in exon1 of the HTT gene that encodes a polyglutamine tract in huntingtin protein. The formation of HTT exon1 fragments with an expanded polyglutamine repeat has been implicated as a key step in the pathogenesis of HD. It was reported that the CAG repeat length-dependent aberrant splicing of exon1 HTT results in a short polyadenylated mRNA that is translated into an exon1 HTT protein. Under normal conditions, TDP-43 is predominantly found in the nucleus, where it regulates gene expression. However, in various pathological conditions, TDP-43 is mislocalized in the cytoplasm. By investigating HD knock-in mice, we explore whether the pathogenic TDP-43 in the cytoplasm contributes to HD pathogenesis, through expressing the cytoplasmic TDP-43 without nuclear localization signal. We found that the cytoplasmic TDP-43 is increased in the HD mouse brain and that its mislocalization could deteriorate the motor and gait behavior. Importantly, the cytoplasmic TDP-43, via its binding to the intron1 sequence (GU/UG)n of the mouse Htt pre-mRNA, promotes the transport of exon1-intron1 Htt onto ribosome, resulting in the aberrant generation of exon1 Htt. Our findings suggest that cytoplasmic TDP-43 contributes to HD pathogenesis via its binding to and transport of nuclear un-spliced mRNA to the ribosome for the generation of a toxic protein product.
More Related Videos
11:22Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
Published on: June 27, 2018
10:52Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021